This page contains a Flash digital edition of a book.
processing | Clean compounding Fundamental elements of best practice


Achieving and maintaining cleanroom operating conditions is not an easy task. However, there are some simple rules that, if followed, can make the process easier, This checklist has been provided by cleanroom expert Dr. Philip R Austin, Chief Executive Officer of Acorn Industries. l Use good cleanroom garments. l Wear clean garments that meet ASTM F51 Class C cleanliness. l Wear protective garments properly, with all closures at neck and wrists secured. l Maintain an effective cleanroom janitorial programme. l Clean the extruders. l Make sure all HEPA filters in the air handling system are secure and not leaking. l Establish a cleanroom monitoring programme. l Train all personnel in cleanroom operation by non-company personnel. The Buddy training system is flawed. l Do not bring cardboard, paper or cellulous products into the cleanroom. l Vacuum the floor at least every other day.


throughout the supply chain in regard to raw materials and finished goods. However, cleaning procedures are obviously the most important elements to clean com- pounding. By following all the procedures, we reduce the chances of contamination and errors. We always say to our employees - if you see something, say something.”


Below: Hexpol TPE started up this new medical TPE line at its Elasto Sweden site last year


Capacity expansions Clariant recently announced expanded production capacities for Mevopur pre-coloured compounds for the medical industry at its ISO13485 sites in Singapore. Mevopur compounds and masterbatches are manufac- tured from pre-tested and batch controlled ingredients that have been biologically evaluated to ISO10993 and USP 87, 88 Class VI. They are compounded at three dedicated GMP ISO 13485’ certified production facilities including Lewiston, Maine, in the US, and Singapore as well as Europe The investment recognises that some customers


prefer to use a fully compounded resin, according to Steve Duckworth, Clariant’s Global Head, Healthcare Polymer Solutions. “A pre-coloured compound may be preferred over a natural/uncoloured resin plus concen-


trate because of technical difficulties with the moulding process or with more ‘difficult’ resins,” he says. “Clariant can give our customers both options with


the assurance that the raw materials, regulatory procedures and processing steps are all controlled in the same way. This allows, for example, a medical device company to validate both concentrate and compound, giving them the flexibility to choose later the route that best meets their processing, economic and technical requirements,” he adds. The investment extends the range of pre-coloured


Mevopur compounds compounded in the US to include melt-processable fluoropolymers, in addition to its existing slate of PP, PE, ABS, PC/ABS, PSU and PEEK. The Singapore facility can now offer PPS. Late last year, Hexpol TPE announced the start-up of a


new medical line and expansion of its technical centre at its Elasto Sweden operation at Åmål (the company claims it was the first European TPE compounder to gain ISO 13485 certification for development, manufacturing, marketing and sales of TPE compounds for medical devices). It will produce the company’s Mediprene grades. “High quality materials, produced under consistent


conditions with a strict raw material selection policy, all backed by specialist technical support, this is what we’ve built our medical strategy on,” says Niklas Ottosson, Medical Technical Manager at Elasto. “Our strong heritage in this sector gives us a deep understanding of medical device regulations and requirements, such as; traceability, reproducibility and formulation stability.”


Click on the links for more information: ❙ www.cleanroom-consulting-group.com (Acorn Ind) ❙ www.fostercomp.comwww.plasticscolor.comwww.clariant.comwww.hexpoltpe.com


22 COMPOUNDING WORLD | April 2016 www.compoundingworld.com


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88